← Back to Patent Explorer
US4421738A Expired / Lapsed US ⏱️ 0.0 years remaining

Sugar-coated tablet containing fat-soluble pharmaceutical material

Assignee: Eisai Co Ltd
•
Filing: 1982-03-18
•
Granted: 1983-12-20
•
Expires: 2002-03-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A sugar-coated tablet for medical use comprising a core containing low-melting fat-soluble pharmaceutical material and a sugar coating layer on said core, which is characterized by the feature that at least one water-soluble cellulose ether coating film is present between the core and the sugar-coating layer.

Inventors

  • 👤 Satoshi Yamagiwa
  • 👤 Yoshio Taguchi
  • 👤 Masanori Kayano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 23:51
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/28; A61K9/2886; A61K9/2806; A61K9/2833; A61K9/286; A61K9/2866

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 119 words
A sugar-coated tablet, comprising: a core containing low-melting, fat-soluble, active pharmaceutical material; a continuous coating film formed in direct contact with and completely covering said core, said coating film consisting of a material selected from the group consisting of (a) a pharmacologically acceptable water-soluble cellulose ether, (b) a mixture of two or more of said cellulose ethers and (c) a mixture of one or more of said cellulose ethers and a plasticizer therefor, said coating film being free of sugar; and a pharmacologically acceptable, sugar, coating layer over said film, said sugar layer being free of water-soluble cellulose ether, said film being effective to prevent migration of said active pharmaceutical material from said core to said sugar coating layer.
Claim 2
Dependent Claim 119 words
A sugar-coated tablet, comprising: a core containing low-melting, fat-soluble, active pharmaceutical material; a continuous coating film formed in direct contact with and completely covering said core, said coating film consisting of a material selected from the group consisting of (a) a pharmacologically acceptable water-soluble cellulose ether, (b) a mixture of two or more of said cellulose ethers and (c) a mixture of one or more of said cellulose ethers and a plasticizer therefor, said coating film being free of sugar; and a pharmacologically acceptable, sugar, coating layer over said film, said sugar layer being free of water-soluble cellulose ether, said film being effective to prevent migration of said active pharmaceutical material from said core to said sugar coating layer.
Claim 3
Dependent Claim 33 words
A sugar-coated tablet as claimed in claim 1 in which said cellulose ether is selected from the group consisting of methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylmethyl cellulose and mixtures thereof.
Claim 4
Dependent Claim 16 words
A sugar-coated tablet as claimed in claim 1 in which said cellulose ether is hydroxypropyl cellulose.
Claim 5
Dependent Claim 26 words
A sugar-coated tablet as claimed in claim 1, claim 2 or claim 3, in which the thickness of said coating film is at least 0.02 mm.
Claim 6
Dependent Claim 27 words
A sugar-coated tablet as claimed in claim 1, claim 2 or claim 3, in which the thickness of said coating film is from 0.05 to 0.2 mm.
Claim 7
Dependent Claim 23 words
A sugar-coated tablet as claimed in claim 1, in which said pharmaceutical material has a melting point of not higher than 70° C.
Claim 8
Dependent Claim 16 words
A sugar-coated tablet as claimed in claim 6, in which said pharmaceutical material is Coenzyme Q.
Claim 9
Dependent Claim 56 words
A sugar-coated tablet as claimed in claim 1, consisting essentially of said core; said coating film; a layer of powder sugar in direct contact with and covering said coating film; a coloring layer in direct contact with and covering said powder sugar layer; and a wax film in direct contact with and covering said coloring layer.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-12-19 1987-06-20 1987-12-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-12-19 1991-06-20 1991-12-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-12-19 1995-06-20 1995-12-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag